Our team validates your insurance and pairs you with an expert provider in Littleton
Conclusion Injection pens play a critical role in the success of GLP-1 therapies
Because each peptide acts on a different node of the same shared pathways (the VEGF axis, NF-kB suppression, ECM remodeling), the combination is theoretically additive rather than redundant
News provided by Designs for Health Jun 17, 2026, 10:17 ET New probiotic and postbiotic blend targets microbiome health, metabolic balance, and healthy body composition through clinically studied ingredients* PALM COAST, Fla., June 17, 2026 /PRNewswire/ -- Designs for Health, the practitioner-recommended and preferred brand for high-quality, research-backed supplements, today announced the launch of Akkermansia Pro GLP-1 Probiotic, a groundbreaking once-daily probiotic and postbiotic formula that combines live Akkermansia muciniphila with the clinically studied BPL1 postbiotic to support the gutmetabolic connection, the body's natural GLP-1 production, and healthy weight management.* As research continues to explore the connection between the gut microbiome and metabolic health, emerging science suggests that specific keystone bacterial strains, those that are foundational to the gut microbiome, may play a vital role in supporting appetite regulation, blood sugar metabolism, gut barrier integrity, and overall metabolic resilience
